Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

Similar documents
MRF. Result Update. Accumulate

Techno Electric & Engineering

Skipper. Result Update. Reduce

Bharat Petroleum Corporation

Transport Corporation of India

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

MRF. Result Update. Accumulate

Result Update. Sterling Tools. Buy

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

Gujarat State Petronet

Result Update. Ahluwalia Contracts. Buy

Result Update. Atul Auto. Accumulate

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

Simplex Infrastructures

NCC. Result Update. Accumulate

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

GSK Pharma. Result Update. Buy

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Result Update. Havells. Buy

Result Update. Sterling Tools. Accumulate

Result Update. Skipper. Sell

Balkrishna Industries

Shemaroo Entertainment

Container Corporation of India

Transport Corporation of India

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

CONCOR. Management Meeting Update. Buy

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Result Update. Tech Mahindra. Buy

Result Update. Khadim India. Buy

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Infosys. Result Update. Buy

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Mahanagar Gas. Result Update. Accumulate

Kajaria Ceramics. Result Update. Buy

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Kalpataru Power Transmission

Result Update. KEI Industries. Buy

Result Update ITC. Accumulate

Result Update. NIIT Technologies. Buy

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Q3FY19 Quarterly Preview IT Services

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

Result Update. HDFC Bank. Accumulate

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

ICICI Bank. Result Update. Buy

KEC International. Annual Report Analysis. Accumulate

Repco Home Finance REPCO IN

Q3FY13 Q3FY12 YOY(%) Q2FY13

Result Update. Yes Bank. Buy

Larsen & Toubro (LT IN)

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Sanofi India. Company Update. Buy

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

South Indian Bank. Result Update. Buy

Bayer Cropscience (BYRCS IN)

Near-term pressure, but long-term outlook positive

Visaka Industries Ltd

Cummins India Ltd Bloomberg Code: KKC IN

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Still on track. Exhibit 1: ICT is on track for FY09E

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Fineotex Chemical Ltd

Simplex Infrastructures

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Ahluwalia Contracts (India)

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

KEC International (KECI IN)

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Tata Steel (TATA IN)

Amber Enterprises India Ltd

TVS Motors. Source: Company Data; PL Research

Transport Corporation of India Ltd.

Bloomberg Code: ATA IN

ITC Ltd. RESULT UPDATE 27th October, 2017

Mahindra & Mahindra Ltd.

Mahindra & Mahindra. Source: Company Data; PL Research

Indian Oil Corporation (IOCL IN)

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Larsen & Toubro. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Mahindra & Mahindra Ltd.

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Larsen & Toubro (LT IN) Well played on all fronts but for margins

Asian Paints. Source: Company Data; PL Research

Transcription:

Result Update Larsen & Toubro Accumulate Q1 was an inline quarter adjusting for IndAS changes and one-off gains. It has held on to its FY19 guidance given at the beginning of the year, making Q1 a non-event in a way. Remains the best proxy for the Indian infrastructure story. Maintain Accumulate with a TP ` 1574 Holds on FY19 guidance: Good inflows in Q1FY19 L&T has maintained a positive outlook FY19, with order inflow guidance of 1-11%, revenue growth of 12-15% accompanied by a 25bps EBIDTA margin improvement. This comes on the back of a decent Q1 with order inflows of ` 36bn, a growth of 37%YoY. While a higher order inflow would have been normal in a pre-election year, the management stated that there would no major front ending but there will be relatively less skew between H2 and H1. Consolidated order book of ` 2.71tn provides strong mediumterm visibility. Q1FY19 inline quarter adjusting for one-offs and IndAS changes Revenues were strong in Q1 with a 18% YoY growth. EBIDTA of ` 29bn in Q1 carries the impact of a one-off gain of ` 3.5bn on account of sale of remaining stake in Kattupalli port and a onetime provision of ` 4.8bn for a sub-judice real estate project. On track with its strategic RoE expansion plan It plans to expand RoE to 18% in FY21, from the current levels of ~13-1. It is working on multiple drivers simultaneously-loss reduction of subsidiaries by sell offs and divestiture, monetizing assets identified as noncore, shifting of plants from prime locations and monetise the real estate, focus on working capital to achieve incremental savings, use of digital and analytics to improve internal productivity etc. Best proxy for the Indian infrastructure story RoE expansion through a combination of balance sheet de-leveraging, incremental operating margin gains, focus on an asset light pure play EPC model should sustain valuations for Larsen. We make cursory changes to our numbers and adjust TP for these and changes subsidiary market caps Accumulate with a TP of ` 1,574. Q1FY18 Result (` Mn) Particulars Q1FY19 Q1FY18 YoY (%) Q4FY18 QoQ (%) Operating Income 282,835 239,898 17.9 46,781 (3.5) Operating Expenditure 172,76 151,447 14. 269,446 (35.9) Staff Expenses 42,815 35,36 21.3 41,284 3.7 Other Expenditure 21,631 18,452 17.2 26,379 (18.) EBITDA 29,133 2,752 4.4 53,95 (46.) Other Income 2,44 3,657 (33.3) 4,328 (43.6) Depreciation 6,449 5,513 17. 4,924 31. Interest 3,648 2,958.1 4,181 (12.8) PBT 21,477 15,253 4.8 49,128 (56.3) Tax 9,346 4,597 13.3 14,58 (35.9) Net Profit 1,798 8,925 21. 31,645 (65.9) bps bps Operating Exp. (%) 61.1 63.1 (27) 66.2 (518) Staff Cost (%) 15.1 14.7 42 1.1 499 Other Expenditure (%) 7.6 7.7 (4) 6.5 116 EBITDA (%) 1.3 8.7 165 13.3 (295) PBT (%) 7.6 6.4 124 12.1 (448) NPM (%) 3.8 3.7 1 7.8 (397) July 26, 218 CMP ` 1,32 Target / Upside ` 1,574/ 19% BSE Sensex 36,858 NSE Nifty 11,132 Scrip Details Equity / FV ` 2,81mn/ 2/- Market Cap ` 1,85bn USD 27bn 52-week High/Low `147/1115 Avg. Volume (no) 2,277,121 NSE Symbol Bloomberg Code Shareholding Pattern Jun 18 (%) LT LT IN Promoters - MF/Banks/FIs 38.3 FIIs 18.3 Public / Others 41.4 Valuation (x) FY18 FY19E FY2E P/E 25.1 22.8 19.6 EV/EBITDA 21. 19.9 18.1 ROE 13.9 14. 15.1 ROCE 8. 8. 8.5 Estimates (` Bn) FY18 FY19E FY2E Net Sales 1,198 1,354 1,517 EBITDA 136 144 161 PAT 74 81 94 EPS (`) 52 58 67 Sr. Analyst: Vinod Chari Tel: +9122 496 9776 E-mail: vinodc@dolatcapital.com Analyst: Jayakanth Kasthuri Tel: +9122 496 9771 E-mail: jayakanthk@dolatcapital.com

SOTP Valuation Target Price ` 1574 Earnings/ Book Value Target P/E, P/B Value Valuation Type L&T Stake Value Per share value (` mn) (X) (` mn) (%) (` mn) (`) Core E&C business (FY2E) 71,68 23 1,646,987 PER 1. 1,646,987 1,175 L&T Infotech 311,67 233,3 25% disc to current Mcap 84. 196,42 14 L&T Tech. services 146,892 11,169 25% disc to current Mcap 88.8 97,841 7 L&T Finance Holdings 367,319 293,855 3% disc to current Mcap 64.1 188,479 134 LT IDPL 46,993 1. 46,993 PBV 97.5 45,794 33 LT Power 31,127 1. 31,127 PBV 1. 31,127 22 1,574 4 35 3 25 2 15 1 5 Order Inflow Mix for Q1FY19 (in ` bn) Q1FY19 Domestic International Q1FY18 Segment-wise Order Inflow Q1FY19 (%) Services 22% Others 3% Hydrocarbon 13% HE+ Defence E&A Infra 5 July 26, 218 2

Segment-wise Order Book Q1FY19 (%) E&A 1% HE+Defence Engg 6% Hydrocarbon 1% Power 3% Others 2% Infra 78% Q1FY19 Revenue Break Up (%) Others 7% Services 27% Infra 42% Hydrocarbon 12% E&A Defence Engg 3% HE 1% Power 3, Order Book as of Jun 18 (in ` bn) 2,5 2, 1,5 1, 5 Q1FY19 International Domestic Q1FY18 July 26, 218 3

Revenue & Revenue growth YoY 1,6 1,4 1,2 1, 8 6 4 2 FY13 FY14 FY15 FY16 FY17 FY18 FY19E FY2E Revenue (` bn) YoY Growth - RHS (%) 3% 25% 2% 15% 1% 5% % -5% EBITDA & EBITDA Growth YoY 18 16 14 12 1 8 6 4 2 FY13 FY14 FY15 FY16 FY17 FY18 FY19E FY2E 25% 2% 15% 1% 5% % -5% -1% -15% -2% EBITDA (` bn) YoY Growth - RHS (%) EBITDA Margin - RHS (%) Net profit & Net profit growth YoY 1 9 8 7 6 5 4 3 2 1 FY13 FY14 FY15 FY16 FY17 FY18 FY19E FY2E Net Profit (` bn) YoY Growth - RHS % NP Margin - RHS (%) 7. 6. 5. 4. 3. 2. 1.. -1. July 26, 218 4

Income Statement (` mn) Particulars Mar17 Mar18P Mar19E Mar2E Net Sales 1,1,11 1,198,621 1,354,442 1,516,975 Total Expenditure 988,82 1,62,9 1,21,166 1,355,387 Operating Expenses 719,785 771,6 88,387 986,34 Employee Expenses 138,54 152,924 172,84 193,541 Selling & Adm. Expenses 13,477 138,916 156,975 175,812 Other Income 13,441 14,11 14,816 15,556 EBIDTA (Excl. OI) 111,38 135,721 144,275 161,587 EBIDTA (Incl. OI) 124,749 149,831 159,91 177,144 Interest 13,398 15,385 16,677 17,511 Depreciation 23,699 19,287 21,49 21,481 Profit Before Tax 88,866 116,312 126,353 146,739 Tax 2,66 31,989 41,696 48,424 Minority Interest 8,395 (1,74) (3,668) (3,937) Net Profit 6,44 73,75 8,989 94,378 Balance Sheet (` mn) Particulars Mar17 Mar18P Mar19E Mar2E Sources of Funds Equity Capital 1,866 2,83 2,83 2,83 Other Reserves 5,299 553,767 597,832 649,183 Net Worth 52,165 556,57 6,635 651,985 Secured Loans 682,654 738,62 775,532 814,39 Unsecured Loans 266,357 346,93 363,398 381,568 Loan Funds 949,11 1,84,695 1,138,93 1,195,877 Deferred Tax Liability (11,252) (14,941) (14,941) (14,941) Total Capital Employed 1,439,924 1,626,325 1,724,625 1,832,922 Applications of Funds Gross Block 171,78 228,877 233,877 238,677 Less: Accumulated Dep. 39,46 58,693 61,627 64,79 Net Block 132,374 17,184 172,249 173,968 Capital Work in Progress 149,665 134,434 145,434 156,434 Investments 114,953 128,43 153,567 159,71 Current Assets, Loans & Advances Inventories 41,397 48,478 54,92 61,51 Sundry Debtors 286,89 346,541 315,418 353,268 Cash and Bank Balance 53,6 8,325 113,626 121,45 Loans and Advances 43,4 312,23 296,864 332,488 Other Current Assets 39,568 465,248 525,731 588,818 sub total 1,21,919 1,252,616 1,36,558 1,457,489 Less: Current Liabilities & Provisions Current Liabilities 62,439 721,82 742,16 831,219 Provisions 26,678 24,838 28,66 31,434 sub total 629,118 746,639 77,226 862,653 Net Current Assets 572,81 55,977 536,332 594,835 Total Assets 1,439,924 1,626,325 1,724,625 1,832,922 E Estimates Cash Flow (` mn) Particulars Mar17 Mar18P Mar19E Mar2E Profit before tax 87,651 115,159 121,365 138,152 Depreciation & w.o. 23,699 19,287 21,49 21,481 Net Interest Exp 13,398 15,385 16,677 17,511 Direct taxes paid (2,66) (31,989) (41,696) (48,424) Change in Working Capital (155,45) 94,9 2,945 (5,725) (A) CF from Opt. Activities (5,722) 211,933 12,34 77,995 Capex (2,85) (41,866) (16,) (15,8) Free Cash Flow (52,87) 17,67 14,34 62,195 (B) CF from Invt. Activities (81,189) (55,343) (41,137) (15,8) Inc./(Dec.) in Debt 61,996 135,684 54,235 56,947 Interest exp net (13,398) (15,385) (16,677) (17,511) Dividend Paid (Incl. Tax) (15,67) (26,91) (36,923) (43,28) (C) CF from Financing 32,93 94,335 634 (3,592) Net Change in Cash (84) 27,266 33,3 7,779 Opening Cash balances 53,899 53,6 8,325 113,626 Closing Cash balances 53,6 8,325 113,626 121,45 Important Ratios Particulars Mar17 Mar18P Mar19E Mar2E (A) Measures of Performance (%) EBIDTA Marg (excl. OI) 1.1 11.3 1.7 1.7 Interest / Sales 1.2 1.3 1.2 1.2 Tax/PBT 22.6 27.5 33. 33. Net Profit Margin 5.5 6.1 6. 6.2 (B) As Percentage of Net Sales Operating Expenses 65.4 64.3 65. 65. Employee Expense 12.6 12.8 12.8 12.8 Other Expenses 11.9 11.6 11.6 11.6 (C) Measures of Financial Status Debt / Equity (x) 1.9 1.9 1.9 1.8 Interest Coverage (x) 9.3 9.7 9.5 1.1 Avg. Cost of Debt (%) 1.5 1.5 1.5 1.5 Debtors Period (days) 95 16 85 85 Invt. Turn. Ratio (x) 27 25 25 25 Fixed Assets Turn. (x) 6.4 5.2 5.8 6.4 WC Turnover (x) 1.9 2.4 2.5 2.6 Non-Cash WC (` Mn) 519,742 425,651 422,76 473,431 (D) Measures of Investment EPS (`) (excl EO) 43.1 52.6 57.8 67.3 CEPS (`) 9.1 66.4 72.8 82.7 DPS (`) 9.3 16. 22. 25.6 Dividend Payout (%) 21.6 3.4 38. 38. Profit Ploughback (%) 78.4 69.6 62. 62. Book Value (`) 538.3 397.2 428.6 465.3 RoANW (%) 12.8 13.9 14. 15.1 RoACE (%) 7. 8. 8. 8.5 RoAIC (%) 7.6 8.9 8.7 9.4 (E) Valuation Ratios CMP (`) 1,32 1,32 1,32 1,32 P/E (x) 3.6 25.1 22.8 19.6 Market Cap. (` Mn) 1,231,541 1,849,852 1,849,852 1,849,852 MCap/ Sales (x) 1.1 1.5 1.4 1.2 EV (` Mn) 2,127,492 2,854,222 2,875,157 2,924,324 EV/Sales (x) 1.9 2.4 2.1 1.9 EV/EBDITA (x) 19.1 21. 19.9 18.1 P/BV (x) 2.5 3.3 3.1 2.8 FCFF Yield (%) (.3) 15.7 7.7 5.5 Dividend Yield (%).7 1.2 1.7 1.9 E Estimates July 26, 218 5

DART RATING MATRIX Total Return Expectation (12 Months) Buy > 2% Accumulate 1 to 2% Reduce to 1% Sell < % Rating and Target Price History 18 Month Rating TP (`) Price (`)* 17 16 Feb-18 Accumulate 1,71 1,456 May-18 Accumulate 1,611 1,359 15 14 13 * As on Recommendation Date 12 11 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 L&T Target DART Team Purvag Shah Managing Director purvag@dolatcapital.com +9122 496 9747 Amit Khurana, CFA Head of Equities amit@dolatcapital.com +9122 496 9745 CONTACT DETAILS Equity Sales Designation E-mail Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com +9122 496 979 Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com +9122 496 9762 Kapil Yadav VP - Equity Sales kapil@dolatcapital.com +9122 496 9735 Kartik Mehta Asia Head Derivatives kartikm@dolatcapital.com +9122 496 9715 Derivatives Strategist Designation E-mail Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com +9122 496 975 Equity Trading Designation E-mail P. Sridhar VP and Head of Sales Trading sridhar@dolatcapital.com +9122 496 9728 Chandrakant Ware AVP - Equity Sales Trading chandrakant@dolatcapital.com +9122 496 977 Derivatives Trading Designation E-mail Shirish Thakkar AVP - Derivatives shirisht@dolatcapital.com +9122 496 972 Hardik Mehta Sales Trader hardikm@dolatcapital.com +9122 496 9748 Dolat Capital Market Private Limited. 2, Rajabahadur Mansion, 1st Floor, Ambalal Doshi Marg, Fort, Mumbai - 4 1

Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a- 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered broker-dealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U6599DD1993PTC9797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB17152 & INF17152, NSE - INB237131& INF237131, Research: INH685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 21, Daman & Diu Board: +9122 49697 Fax: +9122 22651278 Email: research@dolatcapital.com www.dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)